» Articles » PMID: 6124234

An Overview of the Genetics of Psychopathology

Overview
Journal Behav Genet
Date 1982 Feb 1
PMID 6124234
Authors
Affiliations
Soon will be listed here.
Abstract

The suggestion that psychopathologies are in part mediated by aberrant catecholamine metabolism has resulted in one of the more rapidly growing areas of pharmacogenetics. Collectively, the studies conducted to date indicate that psychopathological conditions have multiple causes which cannot be related to single genetic or biochemical deficits. However, through multidisciplinary research integrating behavioral, genetic, and biochemical approaches, a great deal of insight may be gained concerning the causes of psychopathological disorders and the use of drug therapy to modify the course of these illnesses.

References
1.
Pandey G, Dorus E, Shaughnessy R, Davis J . Genetic control of platelet monoamine oxidase activity: studies on normal families. Life Sci. 1979; 25(13):1173-8. DOI: 10.1016/0024-3205(79)90140-1. View

2.
Wyatt R, Potkin S, Murphy D . Platelet monoamine oxidase activity in schizophrenia: a review of the data. Am J Psychiatry. 1979; 136(4A):377-85. View

3.
Kessler S, Ciaranello R, Shire J, Barchas J . Genetic variation in activity of enzymes involved in synthesis of catecholamines. Proc Natl Acad Sci U S A. 1972; 69(9):2448-50. PMC: 426962. DOI: 10.1073/pnas.69.9.2448. View

4.
Stolk J, Hurst J, Van Riper D, Harris P . Genetic analysis of serum dopamine-beta-hydroxylase activity in rats. Mol Pharmacol. 1979; 16(3):922-31. View

5.
Nies A, Robinson D, Lamborn K, Lampert R . Genetic control of platelet and plasma monoamine oxidase activity. Arch Gen Psychiatry. 1973; 28(6):834-8. DOI: 10.1001/archpsyc.1973.01750360060008. View